AKBA R&D Expenses
Akebia Therapeutics Inc · R&D Expenses
AKBA R&D Expenses
Latest reported$14.06Mperiod ending
AKBA Quarterly R&D Expenses ($566.47K → $14.06M)
Quarterly R&D Expenses
High-resolution chart · PNG
AKBA r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 14,059,000 | |
| 14,807,000 | |
| 26,648,000 | |
| 14,626,000 | |
| 11,013,000 | |
| 9,754,000 | |
| 11,786,000 | |
| 8,487,000 | |
| 7,647,000 | |
| 9,731,000 | |
| 9,865,000 | |
| 13,330,000 | |
| 20,197,000 | |
| 19,686,000 | |
| 31,904,000 | |
| 28,028,000 | |
| 26,027,000 | |
| 43,833,000 | |
| 29,556,000 | |
| 40,471,000 | |
| 37,214,000 | |
| 40,611,000 | |
| 37,578,000 | |
| 46,857,000 | |
| 52,819,000 | |
| 81,231,000 | |
| 80,412,000 | |
| 74,512,000 | |
| 85,694,000 | |
| 82,351,000 | |
| 87,113,000 | |
| 70,634,000 | |
| 71,917,000 | |
| 61,404,000 | |
| 68,382,000 | |
| 58,711,000 | |
| 43,751,000 | |
| 60,049,000 | |
| 33,435,000 | |
| 31,238,000 | |
| 30,877,000 | |
| 20,235,000 | |
| 12,539,000 | |
| 15,790,000 | |
| 7,182,000 | |
| 7,505,000 | |
| 7,068,000 | |
| 6,648,000 | |
| 5,524,895 | |
| 6,157,928 | |
| 3,190,600 | |
| 3,240,000 | |
| 2,453,000 | |
| 1,897,795 | |
| 566,471 |